Ameriprise Financial Inc. Raises Position in Allogene Therapeutics, Inc. (NASDAQ:ALLO)
Ameriprise Financial Inc. lifted its stake in Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 14.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 201,943 shares of the company’s stock after acquiring an additional 24,830 shares during the quarter. Ameriprise Financial Inc.’s holdings in Allogene Therapeutics were worth $430,000 as of its […]
